Abstract
The most common brain tumors in children are neuroblastomas, whereas gliomas predominate in adults. Both tumours are known for their aggressive proliferation and diffuse invasive potential. The survival rate for patients with gliomas is less than 50%. However, the prognosis of individual cases with these brain tumours is highly variable and associated with a vast number of biological and clinical features. For example, the mortality in children with stage II and IV, younger than 12 months and with amplification of N-MYC gene exceeds 60%, while almost 100% of children in stage IVS, older than 12 months survive even without treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
